What is the significance of increases in background levels of carcinogen-derived protein and DNA adducts? Some considerations for incremental risk assessment

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 424, Issue 1-2, 1999, Pages 275-286

  Farmer, Peter B ^a   Shuker, David E G ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Analytical method; DNA adduct; Incremental risk assessment; Protein adduct

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 4 BIPHENYLAMINE; 5 HYDROXYMETHYLURACIL; BENZO[A]PYRENE; CARCINOGEN; DIMETHYLNITROSAMINE; ETHYLENE OXIDE; HYDROXYL RADICAL; MALONALDEHYDE; TOBACCO SMOKE;

DNA ADDUCT; DNA REPAIR; HUMAN; MUTAGENICITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0033535423     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00025-1     Document Type: Article

References (88)

1. Bartsch H. DNA adducts in human carcinogenesis: etiological relevance and structure-activity relationship. Mutat. Res. 340:1996;67-79.
2. Poirier M.C. A Weston, Human DNA adduct measurements: state of the art. Environ. Health Perspect. 5:1996;883-893.
3. La D.K., Swenberg J.A. DNA adducts: biological markers of exposure and potential applications to risk assessment. Mutat. Res. 365:1996;129-146.
4. Nath R.G., Randerath K., Li D., Chung F.L. Endogenous production of DNA adducts. Regul. Toxicol. Pharmacol. 23:1996;22-28.
5. Shuker D.E.G., Benford D.J. DNA modification in carcinogen risk assessment in relation to diet: recent advances and some perspectives from a MAFF workshop. Biomarkers. 2:1997;265-278.
6. Lutz W.K. Endogenous genotoxic agents and processes as a basis of spontaneous carcinogenesis. Mutat. Res. 238:1990;287-295.
7. 32P-postlabelling Regul. Toxicol. Pharmacol. 23:1996;14-21.
8. Nestmann E.R., Bryant D.W., Carr C.J. Toxicological significance of DNA adducts: summary of discussions with an expert panel. Regul. Toxicol. Pharmacol. 24:1996;9-18.
9. 32P-postlabeling Chem. Res. Toxicol. 7:1994;733-739.
10. Lin D., Lay Jnr J.O., Bryan M.S., Malaveille C., Friesen M., Bartsch H., Lang N.P., Kadlubar F.F. Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry. Environ. Health Perspect. 102:1994;11-16. Suppl. 6.
11. Foiles P.G., Akerkar S.A., Carmella S.G., Kagan M., Stoner G.D., Resau J.H., Hecht S.S. Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and non-smokers. Chem. Res. Toxicol. 4:1991;364-368.
12. Manchester D.K., Weston A., Choi J.S., Trivers G.E., Fennessey P.V., Quintana E., Farmer P.B., L Mann D., Harris C.C. Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta. Proc. Natl. Acad. Sci. U.S.A. 85:1988;9243-9247.
13. Rouzer C.A., Chaudhary A.K., Nokubo M., Ferguson D.M., Reddy R., Blair I.A., Marnett L.J. Analysis of the malondialdehyde-2′-deoxyguanosine adduct pyrimidopurin.one in human leukocyte DNA by gas chromatography/electron capture/negative chemical ionization/mass spectrometry. Chem. Res. Toxicol. 10:1997;181-188.
14. Chaudhary A.K., Nokubo M., Reddy G.R., Yeola S.N., Morrow J.D., Blair I.A., Marnett L.J. Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. Science. 265:1994;1580-1582.
15. Farooq S., Bailey E., Farmer P.B., Jukes R., Lamb J.H., Hernandez H., Sram R., Topinka J. Determination of cis-thymine glycol in DNA by gas chromatography-mass spectrometry with selected ion recording and multiple reaction monitoring. J. Chromatogr. B. 702:1997;49-60.
16. Djuric Z., Heilbrun L.K., Reading B.A., Boomer A., Valeriote F.A., Martino S. Effects of a low fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. J. Nat. Cancer Inst. 83:1991;766-769.
17. Wu K.Y., Ranasinghe A., Upton P., Scheller N., Swenberg J.A. Endogenous formation of the major DNA adduct of ethylene oxide in humans, rats, and mice. Proc. AACR. 37:1996;102.
18. Yen T.Y., Christova-Gueoguieva N.I., Scheller N., Holt S., Swenberg J.A., Charles M.J. Quantitative analysis of the DNA adduct N2,3-ethenoguanine using liquid chromatography/electrospray ionization mass spectrometry. Mass Spectrom. 31:1996;1271-1276.
19. Douki T., Delatour T., Bianchini F., Cadet J. Observation and prevention of an artefactual formation of oxidised DNA bases and nucleosides in the GC-EIMS method. Carcinogenesis. 17:1996;347-353.
20. Ravanat J.L., Turesky R.J., Gremaud E., Trudel L.J., Stadler R.H. Determination of 8-oxoguanine in DNA by gas chromatography-mass spectrometry and HPLC-electrochemical detection: overestimation of the background level of the oxidized base by the gas chromatography-mass spectrometry assay. Chem. Res. Toxicol. 8:1995;1039-1045.
21. Ravanat J.L., Douki T., Turesky R., Cadet J. Measurement of oxidized bases in DNA. Comparison between HPLC-EC and GC-MS assays. J. Chim. Phys. Phys-Chim. Biol. 94:1997;306-312.
22. Rojas M., Alexandrov K., Van Schooten F.J., Hillebrand M., Kriek E., Bartsch H. Validation of a new fluorometric assay for benzo[a]pyrene diolepoxide-DNA adducts in human white blood cells: comparisons with 32P-postlabeling and ELISA. Carcinogenesis. 15:1994;557-560.
23. Degan P., Bonassi S., De Caterina M., Korkina L.G., Pinto L., Scopacassa F., Latterale A., Calzone R., Pagano G. In vivo accumulation of 8-hydroxy-2′deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis. 16:1995;735-741.
24. 32P-postlabelling assay Carcinogenesis. 13:1992;1053-1074.
25. 32P-postlabelling assay Mutat. Res. 378:1997;1-12.
26. 32P-postlabelled DNA adducts J. Chromatogr. B. Biomed. Appl. 677:1996;265-273.
27. Wild C.P. Antibodies to DNA alkylation adducts as analytical tools in chemical carcinogenesis. Mutat. Res. 233:1990;219-233.
28. Hemminki K., Autrup H., Haugen A. DNA and protein adducts. Toxicology. 101:1995;41-53.
29. 6-methylguanine in alkylated DNA. Biochemistry. 17:1978;1896-1901.
30. 6-methylguanine in mouse liver satellite and main-band DNA following dimethylnitrosamine administration. J. Cancer Res. Clin. Oncol. 98:1980;127-138.
31. Müller R., Rajewsky M.F. Antibodies specific for DNA components structurally modified by chemical carcinogens. J. Cancer Res. Clin. Oncol. 102:1981;99-113.
32. Adamkiewicz J., Eberle G., Huh N., Nehls P., Rajewsky M.F. Quantitation and visualisation of alkyl deoxynucleosides in the DNA of mammalian cells by monoclonal antibodies. Environ. Health Perspect. 62:1985;49-55.
33. 6-methyldeoxyguanosine in DNA of cells alkylated in vitro and in vivo. Carcinogenesis. 4:1983;1605-1609.
34. 6-methyldeoxyguanosine in DNA methylated by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyndyl)-1-butanone using a biotin-avidin enzyme-linked immunosorbent assay. Carcinogenesis. 6:1985;989-993.
35. 6-methylguanine in target cell nuclei of dimethylnitrosamine-treated human pancreas by a murine monoclonal antibody. Carcinogenesis. 8:1987;839-846.
36. 6-methyldeoxyguanosine in human placental DNA. Cancer Res. 48:1988;4184-4188.
37. 6-(2-hydroxyethyl)-2′-deoxyguanosine in DNA of various rat tissues following a single dose of N-nitroso-N-(2-hydroxyethyl)urea. An immunoslot-blot study. Carcinogenesis. 9:1988;147-151.
38. 6-ethyldeoxyguanosine in DNA exposed to the carcinogen ethylnitrosourea in vivo or in vitro. Z. Naturforsch. 33c:1978;897-901.
39. 6-ethyldeoxyguanosine in DNA exposed to N-ethyl-N-nitrosourea. Cancer Res. 40:1980;887-896.
40. M.F. Rajewsky, R. Müller, J. Adamkiewicz, W. Drosdziok, Immunological detection and quantification of DNA components structurally modified by alkylating carcinogens (ethylnitrosourea), in: B. Pullman, P.O.P. Ts'o, H. Gelboin (Eds.), Fundamental Mechanisms and Environmental Effects, Reidel, Dordrecht, 1980, pp. 207-218.
41. 6-ethyldeoxyguanosine and N-(deoxyguanosin-8-yl)-N-acetyl-2-aminofluorene in DNA by high sensitivity enzyme immunoassays. Carcinogenesis. 3:1982;569-572.
42. 6-ethyldeoxyguanosine in ENU alkylated DNA by polyclonal and monoclonal antibodies. Carcinogenesis. 5:1984;1145-1150.
43. J. Adamkiewicz, W. Drosdziok, W. Eberhardt, U. Langenberg, M.F. Rajewsky, High affinity monoclonal antibodies specific for DNA components structurally modified by alkylating agents, in: B.A. Bridges, B.E. Butterworth, I.B. Weinstein (Eds.), Indicators of Genotoxic Exposure, Banbury Report 13, CSH Laboratory New York, 1982, pp. 265-276.
44. 4-n-butylthymidine. Carcinogenesis. 3:1982;547-552.
45. C.P. Wild, S.H. Lu, R. Montesano, Radioimmunoassay used to detect DNA alkylation adducts in tissues from populations at high risk for oesophageal and stomach cancer, in: H. Bartsch, I.K. O'Neill, R. Schulte-Hermann (Eds.), Relevance of N-Nitroso Compounds to Human Cancer: Exposures and Mechanisms, IARC Scientific Publication No. 84, International Agency for Research on Cancer, Lyon France, 1987, pp. 534-537.
46. 4-ethylthymidine in alkylated DNA: repair of minor miscoding base in human cells. Carcinogenesis. 8:1987;1137-1144.
47. Strickland P.T., Boyle J.M. Immunoassay of carcinogen-modified DNA. Prog. Nucleic Acid Res. Mol. Biol. 31:1984;1-58.
48. 6-carboxymethyl-2′-deoxyguanosine: a DNA adduct formed by nitrosated glycine derivatives. Chem. Res. Toxicol. 10:1997;652-659.
49. Sevilla C.L., Mahle N.H., Eliezer N., Uzieblo A., O'Hara S.M., Nokubo M., Millar R., Rouzer C.A., Marnett L.J. Development of monoclonal antibodies to the malondialdehyde-deoxyguanosine adduct, pyrimidopurinone. Chem. Res. Toxicol. 10:1997;172-180.
50. 4-etheno-2′-deoxycytidine detected by monoclonal antibodies in lung and liver DNA of rats exposed to vinyl chloride. Carcinogenesis. 10:1989;209-210.
51. Degan P., Montesano R., Wild C. Antibodies against 7-methyldeoxyguanosine: its detection in rat peripheral blood lymphocyte DNA and potential applications to molecular epidemiology. Cancer Res. 48:1988;5065-5070.
52. Stein A.M., Gratzner N.C., Stein J.H., McCabe M.M. High avidity monoclonal antibody to imidazole ring-opened 7-methylguanine. Carcinogenesis. 10:1989;927-931.
53. van Delft J.H.M., van Winden M.J.M., Luiten-Schuite A., Ribeiro L.R., Baan R.A. Comparison of various immunochemical assays for the detection of ethylene oxide-DNA adducts with monoclonal antibodies against imidazole ring-opened N7-(2-hydroxyethyl)guanosine: application in a biological monitoring study. Carcinogenesis. 15:1994;1867-1873.
54. van Delft J.H.M., van Weert E.J.M., van Winden M.J.M., Baan R.A. Determination of N7-(2-hydroxyethyl)guanine by HPLC with electrochemical detection. Chem.-Biol. Interactions. 80:1991;281-289.
55. Friesen M.D., Garren L., Prevost V., Shuker D.E.G. Isolation of urinary 3-methyladenine using immunoaffinity columns prior to determination by low-resolution gas chromatography-mass spectrometry. Chem. Res. Toxicol. 4:1991;102-106.
56. Prevost V., Shuker D.E.G., Bartsch H., Pastorelli R., Stillwell W.G., Trudel L.J., Tannenbaum S.R. The determination of urinary 3-methyladenine by immunoaffinity chromatography-monoclonal antibody-based ELISA: use in human biomonitoring studies. Carcinogenesis. 11:1990;1747-1751.
57. Eberle G., Glusenkamp K.H., Drosdziok W., Rajewsky M.F. Monoclonal antibodies for the specific detection of 3-alkyladenines in nucleic acids and body fluids. Carcinogenesis. 11:1990;1753-1759.
58. Durand M.J., Shuker D.E.G. Preparation of compound-specific and group-specific antibodies to 7-methylguanine and related 7-alkylguanines and their use in immunoaffinity purification. Carcinogenesis. 15:1994;957-961.
59. R.R. Rana, M.-J. Durand, D. Molko, E. Bowman, A. Weston, R. Singh, J.H. Lamb, A. Larkins, R.F.L. James, D.E.G. Shuker, Detection and quantitation of 7-alkylguanines by immunoaffinity-fluorescent postlabelling, Chem. Res. Toxicol. (1999) (in press).
60. Casale G.P., Rogan E.G., Stack D., Devansen P., Cavalieri E.L. Production of a high affinity monoclonal antibody specific for 7-(benzo[a]pyrene-6-yl)guanine and its application in a competitive enzyme-linked immunosorbent assay. Chem. Res. Toxicol. 9:1996;1037-1043.
61. Poirier M., Santella R., Weinstein I.B., Grunberger D., Yuspa S.H. Quantitation of benzo(a)pyrene-deoxyguanosine adducts by radioimmunoassay. Cancer Res. 40:1980;412-416.
62. Groopman J.D., Trudel L.J., Donahue P.R., Marshak-Rothstein A., Wogan G.N. High-affinity monoclonal antibodies for aflatoxins and their application to solid-phase immunoassays. Proc. Natl. Acad. Sci. U.S.A. 81:1984;7728-7731.
63. Nehls P., Adamkiewicz J., Rajewesky M.F. Immunoslot-blot: a highly sensitive immunoassay for the quantification of carcinogen-modified nucleosides in DNA. J. Cancer Res. Clin. Oncol. 108:1984;23-29.
64. Leuratti C., Singh R., Lagneau C., Plastaras J., Marnett L.J., Farmer P.B., Shuker D.E.G. Quantitation of malondialdehyde-guanine adducts in DNA of human tissues using an immunoslotblot method. Carcinogenesis. 11:1998;1919-1924.
65. Nakamura J., Walker V.E., Upton P.B., Chiang K.Y., Kow Y.W., Swenberg J.A. Highly sensitive apurinic/apyrimidinic site assay can detect spontaneous and chemically induced depurination under physiological conditions. Cancer Res. 58:1998;222-225.
66. Farmer P.B. Monitoring of human exposure to carcinogens through DNA and protein adduct determination. Toxicol. Lett. 82/83:1995;757-762.
67. Törnqvist M., Mowrer J., Jensen S., Ehrenberg L. Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Anal. Biochem. 154:1986;255-266.
68. Bryant M.S., Skipper P.L., Tannenbaum S.R., Maclure M. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res. 47:1987;602-608.
69. Törnqvist M., Kautiainen A. Adducted proteins for identification of endogenous electrophiles. Environ. Health Perspect. 99:1992;39-44.
70. Fang J.L., Vaca C.E., Valsta L.M., Mutanen M. Determination of DNA adducts of malonaldehyde in humans: effects of dietary fatty acid composition. Carcinogenesis. 17:1996;1035-1040.
71. C.P. Wild, R. Montesano, Detection of alkylated DNA adducts in human tissues, in: J.D. Groopman, P.L. Skipper (Eds.), Molecular Dosimetry and Human Cancer: Analytical, Epidemiological and Social Considerations, CRC Press, Boca Raton, FL, 1991, pp. 263-280.
72. 6-methylguanine in human DNA Carcinogenesis. 16:1995;1665-1669.
73. Peto R., Gray R., Brantom P., Grasso P. Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res. 51:1991;6415-6451.
74. 6-methylguanine. Cancer Res. 49:1989;6997-7001.
75. 6-methylguanine in DNA. Cancer Res. 57:1997;366-369.
76. Taverna P., Sedgwick B. Generation of an endogenous DNA-methylating agent by nitrosation in Escherichia coli. J. Bacteriol. 178:1996;5105-5111.
77. Sedgwick B. Nitrosated peptides and polyamines as endogenous mutagens in O-6-alkylguanine-DNA alkyltransferase deficient cells. Carcinogenesis. 18:1997;1561-1567.
78. Walker V.E., Fennell T.R., Upton P.B., MacNeela J.P., Swenberg J.A. Molecular dosimetry of DNA and hemoglobin adducts in mice and rats exposed to ethylene oxide. Environ. Health Perspect. 99:1993;11-17.
79. Farmer P.B., Cordero R., Autrup H. Monitoring human exposure to 2-hydroxyethylating carcinogens. Environ. Health Perspect. 104:1996;449-452.
80. Filser J.G., Denk B., Tornqvist M., Kessler W., Ehrenberg L. Pharmacokinetics of ethylene in man; body burden with ethylene oxide and hydroxyethylation of hemoglobin due to endogenous and environmental ethylen. Arch. Toxicol. 66:1992;157-163.
81. Qian G.S., Ross R.K., Yu M.C., Yuan J.M., Gao Y.T., Henderson B.E., Wogan G.N., Groopman J.D. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomarkers Prev. 3:1994;3-10.
82. Rothman N., Correa-Villasenor A., Ford D.P., Poirier M.C., Haas R., Hansen J.A., O'Toole T., Strickland P.T. Contribution of occupation and diet to white blood cell polycyclic aromatic hydrocarbon-DNA adducts in wildland firefighters. Cancer Epidemiol. Biomarkers Prev. 2:1993;341-347.
83. Poirier M.C. DNA adducts as exposure biomarkers and indicators of cancer risk. Environ. Health Perspect. 105:1997;907-912. Suppl 4.
84. Shigenaga M.K., Gimeno C.J., Ames B.N. Urinary 8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc. Natl. Acad. Sci. U.S.A. 86:1989;9697-9701.
85. Loft S., Vistisen K., Ewertz M., Tjønneland A., Overvad K., Poulsen H.E. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis. 13:1992;2241-2247.
86. Verhagen H., Poulsen H.E., Loft S., van Poppel G., Willems M.I., van Bladeren P.J. Reduction of oxidative DNA-damage in humans by Brussels sprouts. Carcinogenesis. 16:1995;969-970.
87. Poirier M.C., Beland F.A. DNA adduct measurements and tumour incidence during chronic carcinogen exposure in animal models: implications for DNA adduct-based human cancer risk assessment. Chem. Res. Toxicol. 5:1992;749-755.
88. 6-methylguanine in rat DNA after low-dose, chronic exposure to N-nitrosodimethylamine (NDMA): implications for the mechanism of NDMA carcinogenesis. Carcinogenesis. 16:1995;2381-2387.